258 related articles for article (PubMed ID: 20681406)
1. The inhibitor of growth 1 (ING1) is involved in trichostatin A-induced apoptosis and caspase 3 signaling in p53-deficient glioblastoma cells.
Tamannai M; Farhangi S; Truss M; Sinn B; Wurm R; Bose P; Henze G; Riabowol K; von Deimling A; Tallen G
Oncol Res; 2010; 18(10):469-80. PubMed ID: 20681406
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of the inhibitor of growth 1 (ING1) tumor suppressor sensitizes p53-deficient glioblastoma cells to cisplatin-induced cell death.
Tallen UG; Truss M; Kunitz F; Wellmann S; Unryn B; Sinn B; Lass U; Krabbe S; Holtkamp N; Hagemeier C; Wurm R; Henze G; Riabowol KT; von Deimling A
J Neurooncol; 2008 Jan; 86(1):23-30. PubMed ID: 17763999
[TBL] [Abstract][Full Text] [Related]
3. The inhibitor of growth 1 (ING1) proteins suppress angiogenesis and differentially regulate angiopoietin expression in glioblastoma cells.
Tallen G; Farhangi S; Tamannai M; Holtkamp N; Mangoldt D; Shah S; Suzuki K; Truss M; Henze G; Riabowol K; von Deimling A
Oncol Res; 2009; 18(2-3):95-105. PubMed ID: 20066899
[TBL] [Abstract][Full Text] [Related]
4. P53-dependent antiproliferative and pro-apoptotic effects of trichostatin A (TSA) in glioblastoma cells.
Bajbouj K; Mawrin C; Hartig R; Schulze-Luehrmann J; Wilisch-Neumann A; Roessner A; Schneider-Stock R
J Neurooncol; 2012 May; 107(3):503-16. PubMed ID: 22270849
[TBL] [Abstract][Full Text] [Related]
5. p53 in trichostatin A induced C6 glioma cell death.
Hsu YF; Sheu JR; Hsiao G; Lin CH; Chang TH; Chiu PT; Wang CY; Hsu MJ
Biochim Biophys Acta; 2011 May; 1810(5):504-13. PubMed ID: 21376104
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition by the tumor suppressor p33ING1 in immortalized and primary cells: involvement of two silencing domains and effect of Ras.
Goeman F; Thormeyer D; Abad M; Serrano M; Schmidt O; Palmero I; Baniahmad A
Mol Cell Biol; 2005 Jan; 25(1):422-31. PubMed ID: 15601862
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors induce in human hepatoma HepG2 cells acetylation of p53 and histones in correlation with apoptotic effects.
Carlisi D; Vassallo B; Lauricella M; Emanuele S; D'Anneo A; Di Leonardo E; Di Fazio P; Vento R; Tesoriere G
Int J Oncol; 2008 Jan; 32(1):177-84. PubMed ID: 18097557
[TBL] [Abstract][Full Text] [Related]
8. The histone deacetylase inhibitor trichostatin a promotes apoptosis and antitumor immunity in glioblastoma cells.
Höring E; Podlech O; Silkenstedt B; Rota IA; Adamopoulou E; Naumann U
Anticancer Res; 2013 Apr; 33(4):1351-60. PubMed ID: 23564772
[TBL] [Abstract][Full Text] [Related]
9. Trichostatin A inhibits proliferation and induces expression of p21WAF and p27 in human brain tumor cell lines.
Wang ZM; Hu J; Zhou D; Xu ZY; Panasci LC; Chen ZP
Ai Zheng; 2002 Oct; 21(10):1100-5. PubMed ID: 12508652
[TBL] [Abstract][Full Text] [Related]
10. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
[TBL] [Abstract][Full Text] [Related]
11. Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner.
Zhu Z; Luo Z; Li Y; Ni C; Li H; Zhu M
Hepatology; 2009 Feb; 49(2):504-12. PubMed ID: 19085961
[TBL] [Abstract][Full Text] [Related]
12. Human ING1 proteins differentially regulate histone acetylation.
Vieyra D; Loewith R; Scott M; Bonnefin P; Boisvert FM; Cheema P; Pastyryeva S; Meijer M; Johnston RN; Bazett-Jones DP; McMahon S; Cole MD; Young D; Riabowol K
J Biol Chem; 2002 Aug; 277(33):29832-9. PubMed ID: 12015309
[TBL] [Abstract][Full Text] [Related]
13. The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and apoptosis in colorectal cancer cells via p53-dependent and -independent pathways.
Meng J; Zhang HH; Zhou CX; Li C; Zhang F; Mei QB
Oncol Rep; 2012 Jul; 28(1):384-8. PubMed ID: 22552631
[TBL] [Abstract][Full Text] [Related]
14. Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis.
Wetzel M; Premkumar DR; Arnold B; Pollack IF
J Neurosurg; 2005 Dec; 103(6 Suppl):549-56. PubMed ID: 16383255
[TBL] [Abstract][Full Text] [Related]
15. Deletion of p37Ing1 in mice reveals a p53-independent role for Ing1 in the suppression of cell proliferation, apoptosis, and tumorigenesis.
Coles AH; Liang H; Zhu Z; Marfella CG; Kang J; Imbalzano AN; Jones SN
Cancer Res; 2007 Mar; 67(5):2054-61. PubMed ID: 17332334
[TBL] [Abstract][Full Text] [Related]
16. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors.
Terui T; Murakami K; Takimoto R; Takahashi M; Takada K; Murakami T; Minami S; Matsunaga T; Takayama T; Kato J; Niitsu Y
Cancer Res; 2003 Dec; 63(24):8948-54. PubMed ID: 14695212
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells.
Gilardini Montani MS; Granato M; Santoni C; Del Porto P; Merendino N; D'Orazi G; Faggioni A; Cirone M
Cell Oncol (Dordr); 2017 Apr; 40(2):167-180. PubMed ID: 28160167
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor of growth 1 (ING1) acts at early steps of multiple DNA repair pathways.
Ceruti JM; Ogara MF; Menéndez C; Palmero I; Cánepa ET
Mol Cell Biochem; 2013 Jun; 378(1-2):117-26. PubMed ID: 23459830
[TBL] [Abstract][Full Text] [Related]
19. Trichostatin A, a histone deacetylase inhibitor, suppresses JAK2/STAT3 signaling via inducing the promoter-associated histone acetylation of SOCS1 and SOCS3 in human colorectal cancer cells.
Xiong H; Du W; Zhang YJ; Hong J; Su WY; Tang JT; Wang YC; Lu R; Fang JY
Mol Carcinog; 2012 Feb; 51(2):174-84. PubMed ID: 21520296
[TBL] [Abstract][Full Text] [Related]
20. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.
Hrgovic I; Doll M; Kleemann J; Wang XF; Zoeller N; Pinter A; Kippenberger S; Kaufmann R; Meissner M
BMC Cancer; 2016 Sep; 16(1):763. PubMed ID: 27716272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
